Author

R. E. Tay

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:organoid / primary culture· 1

Frequent Co-Authors

D. Fukumura· 1 shared G. Ferraro· 1 shared H.-J. Kim· 1 shared I. L. Gomes Dos Santos· 1 shared J. Ren· 1 shared K. Kawaguchi· 1 shared N. Wang· 1 shared P. Andersson· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

D. Fukumura

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Combined blockade of VEGF, Angiopoietin-2, and PD1 reprograms glioblastoma endothelial cells into quasi-antigen-presenting cells

Z. Amoozgar, J. Ren, N. Wang, T. P. Uccello, P. Andersson, G. Ferraro, S. Rajan, P. Lei, S. Subudhi, K. Kawaguchi, R. E. Tay, I. L. Gomes Dos Santos, P. Huang, H.-J. Kim, D. Fukumura, R. Jain

This study shows that blocking VEGF, Ang2, and PD1 reprograms GBM endothelial cells into quasi-antigen-presenting cells, enhancing anti-tumor responses and controlling edema.

bioRxiv · Sep 3, 2022 · PreprintCancer Biology